NASDAQ •
Healthcare •
Diagnostics & Research •
Quote as of 05/22/2026
Company Profile
IndustryDiagnostics & Research
SectorHealthcare
ExchangeNASDAQ
Market Capitalization3,663.73 mln
Float55.38 mln
Earnings Date07/31/2026
Piotroski F-Score
4
/ 9
Borderline
Beneish M-Score
-2.71
Likely reliable
1-Year Forecast
63.33
Fairly priced
Relative Strength
88
/ 100
Strongly outperforming
Debt / Equity
0.21
Very low leverage
ROE
-17.65
Negative
Business Description
Twist Bioscience, founded in 2013 and based in South San Francisco, California, develops and sells a broad range of synthetic biology products built on its proprietary DNA synthesis technology. Its offerings span synthetic genes, DNA fragments, oligo pools, and gene libraries used by pharmaceutical, biotechnology, agricultural, and academic organizations for applications including drug discovery, diagnostics, genetic research, and data storage. The company also produces next-generation sequencing tools, methylation detection kits, antibody engineering solutions, and viral reference controls used in the study and detection of diseases such as COVID-19, monkeypox, and influenza.
